Interview by Dr Neil Love and companion faculty lecture recorded on August 25, 2026. Published September 2026.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
AMA PRA Category 1 Credit™Up to 0.75 credits
MOC types
ABIM — Medical KnowledgeUp to 0.75 points
FDA REMS
No
Qualifies for MIPS
No
Target Specialties
Address:
- 2 South Biscayne Blvd
Pricing
100% of listed courses are free
240 of 240 courses listed here are free.
Collected from the provider’s public pages
Specialties served/covered
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- Credit · Up to 0.75 credits
- MOC · Up to 0.75 points
-
ReleasedSep 23, 2026
-
Last day to claim creditSep 25, 2027 12 months left
-
Research to Practice Oncology Today with Dr Neil Love: Optimizing the Use of Antibody-Drug Conjugates for Multiple Myeloma | 2026 (Interview)
-
Research to Practice Oncology Today with Dr Neil Love: Novel Investigational Antibody-Drug Conjugates for Ovarian Cancer | 2026 (Video Lecture)
-
Research to Practice Oncology Today with Dr Neil Love: The Potential Role of TROP2- and CDH6-Directed Antibody-Drug Conjugates in Gynecologic Cancers (Interview)
-
Clinical Care Options, LLC (dba Decera Clinical Education) Advances in Bispecific Antibody Therapy for Multiple Myeloma: Strategies to Personalize Treatment and Elevate Patient Outcomes
-
Efficient CME, CME Outfitters, LLC From Trial to Treatment: Using Modern Evidence, Expert Insight, and Practice Simulation to Navigate the Integration of Bispecific Antibodies into the Care of Patients with Multiple Myeloma
-
Global Learning Collaborative The Frontline Imperative: Integrating Anti-CD38 Based Regimens Into Multiple Myeloma Care in Community Practice
